Literature DB >> 26077344

[Artificial vitreous body: Strategies for vitreous body substitutes].

S Mariacher1, P Szurman.   

Abstract

BACKGROUND: Although numerous advances have been made in technology and techniques of pars plana vitrectomy and tamponades, there are still unsolved issues, such as proliferative vitreoretinopathy (PVR), multiple retinal breaks and persistent hypotonia. All available internal tamponades (e.g, gases, oils and fluorocarbons) are hydrophobic, so they approximate the neurosensory retina to the retinal pigment epithelium due to buoyant force and surface tension. Even though these tamponade materials exhibit various beneficial attributes in the clinical application, the hydrophobic nature has clear disadvantages and compartmentalization and significant incidence of PVR development still occur. RESULTS AND
CONCLUSION: An ideal vitreous body substitute should mimic the native human vitreous body, in both form and function. Vitreous body substitutes, such as hydrogels fulfill the biophysical needs in a similar manner to the natural vitreous body by providing an internal tamponade effect through swelling pressure and viscosity. New approaches range from cross-linked semisynthetic to synthetic polymers. These hydrogels have a good biocompatibility, optical clarity, a refractive index and rheological properties that are similar to the natural human vitreous body and are able to act as anti-adhesive and anti-migrative agents and can therefore reduce PVR. Furthermore, hydrogels could also serve as controlled-release drug-delivery systems for anti-proliferative, neuroprotective or nutritive drugs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26077344     DOI: 10.1007/s00347-015-0057-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Giant retinal tears. Surgical techniques and results using perfluorocarbon liquids.

Authors:  S Chang; H Lincoff; N J Zimmerman; W Fuchs
Journal:  Arch Ophthalmol       Date:  1989-05

2.  Collagen vitreous substitute. I. Experimental study.

Authors:  R C Pruett; G A Calabria; C L Schepens
Journal:  Arch Ophthalmol       Date:  1972-11

3.  Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery.

Authors:  Wenping Shi; Yanwen Ji; Xinge Zhang; Shujun Shu; Zhongming Wu
Journal:  J Pharm Sci       Date:  2010-09-22       Impact factor: 3.534

4.  The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute.

Authors:  Charlotte Schramm; Martin S Spitzer; Sigrid Henke-Fahle; Gabriele Steinmetz; Kai Januschowski; Peter Heiduschka; Jürgen Geis-Gerstorfer; Tilo Biedermann; Karl U Bartz-Schmidt; Peter Szurman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-02       Impact factor: 4.799

5.  Low viscosity liquid fluorochemicals in vitreous surgery.

Authors:  S Chang
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

6.  Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute.

Authors:  Y Hong; T V Chirila; S Vijayasekaran; P D Dalton; S G Tahija; M J Cuypers; I J Constable
Journal:  J Biomed Mater Res       Date:  1996-04

7.  Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy.

Authors:  H Lewis; J M Burke; G W Abrams; T M Aaberg
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

8.  Sodium hyaluronate gels as a drug-release system for corticosteroids: release kinetics and antiproliferative potential for glaucoma surgery.

Authors:  Martin S Spitzer; Efdal Yoeruek; Radoslaw T Kaczmarek; Ana Sierra; Sabine Aisenbrey; Salvatore Grisanti; Karl U Bartz-Schmidt; Peter Szurman
Journal:  Acta Ophthalmol       Date:  2008-12       Impact factor: 3.761

9.  Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo.

Authors:  Britta M Rauck; Thomas R Friberg; Carlos A Medina Mendez; Daewon Park; Veeral Shah; Richard A Bilonick; Yadong Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-23       Impact factor: 4.799

10.  Hyaluronic acid vitreous substitute. A six-year clinical evaluation.

Authors:  R C Pruett; C L Schepens; D A Swann
Journal:  Arch Ophthalmol       Date:  1979-12
View more
  2 in total

1.  Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute.

Authors:  Kai Januschowski; Sven Schnichels; José Hurst; Christine Hohenadl; Charlotte Reither; Annekatrin Rickmann; Lisa Pohl; Karl-Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

2.  Study on the effectiveness and safety of Foldable Capsular Vitreous Body implantation.

Authors:  Xiangyang Zhang; Xuemin Tian; Baike Zhang; Lisa Guo; Xiaodan Li; Yong Jia
Journal:  BMC Ophthalmol       Date:  2019-12-18       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.